Projected Income Statement: Neuronetics, Inc.

Forecast Balance Sheet: Neuronetics, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt - - - - - - - -
Change - - - - - - - -
Announcement Date 08/03/22 07/03/23 05/03/24 04/03/25 17/03/26 - - -
Estimates

Cash Flow Forecast: Neuronetics, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025
CAPEX 1 0.73 2.353 3.269 2.369 1.466 0.801
Change - 222.33% 38.93% -27.53% -38.12% -45.36%
Free Cash Flow (FCF) 1 -17.14 -16.04 -20.12 -20.25 -17.61 -10.41
Change - 6.4% -25.45% -0.63% 13.03% 40.87%
Announcement Date 02/03/21 08/03/22 07/03/23 08/03/24 27/03/25 17/03/26
1USD in Million
Estimates

Forecast Financial Ratios: Neuronetics, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

         
EBITDA Margin (%) - -47.21% -37.91% -40.01% -28.56% -14.16% -8.44% -4.04% -0.9%
EBIT Margin (%) - -49.83% -53.85% -42.82% -45.69% -21.08% -15.52% -10.42% -7.79%
EBT Margin (%) - -56.39% -56.99% -42.31% -57.99% -26.24% -20.38% -14.93% -11.61%
Net margin (%) - -56.39% -56.99% -42.31% -57.99% -26.24% -20.36% -14.93% -12.02%
FCF margin (%) - - - - - - - - -
FCF / Net Income (%) - - - - - - - - -

Profitability

         
ROA -14.34% -15.39% -16.71% -15.34% -16.54% -13.73% - - -
ROE -74.86% -56.37% -52.25% -66.17% -132.53% -134.86% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - - - - - - - -
Debt / Free cash flow - - - - - - - - -

Capital Intensity

         
CAPEX / Current Assets (%) - - - - - - - - -
CAPEX / EBITDA (%) - - - - - - - - -
CAPEX / FCF (%) - - - - - - - - -

Items per share

         
Cash flow per share 1 - - - - - - - - -
Change - - - - - - - - -
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - - - - - - - - -
Change - - - - - - - - -
EPS 1 - -1.22 -1.38 -1.05 -1.37 -0.59 -0.465 -0.3375 -0.3
Change - - -13.11% 23.91% -30.48% 56.93% 21.19% 27.42% 11.11%
Nbr of stocks (in thousands) - 26,368 27,221 28,933 55,652 68,486 69,588 69,588 69,588
Announcement Date - 08/03/22 07/03/23 05/03/24 04/03/25 17/03/26 - - -
1USD
Estimates
2026 *2027 *
P/E -4.34x -5.99x
PBR - -
EV / Sales 0.87x 0.79x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.020USD
Average target price
4.500USD
Spread / Average Target
+122.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STIM Stock
  4. Financials Neuronetics, Inc.